Format

Send to

Choose Destination
Lancet. 2014 Sep 20;384(9948):1096. doi: 10.1016/S0140-6736(14)61672-X.

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes.

Author information

1
Department of of Clinical Medicine and Surgery, Federico II University, Naples 80138, Italy; Società Italiana di Diabetologia, Rome, Italy. Electronic address: tosca@siditalia.it.
2
Department of of Clinical Medicine and Surgery, Federico II University, Naples 80138, Italy; Società Italiana di Diabetologia, Rome, Italy.
3
Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Verona Medical School and Azienda Ospedaliera Universitaria Integrata, Verona, Italy; Società Italiana di Diabetologia, Rome, Italy.
4
Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy; Società Italiana di Diabetologia, Rome, Italy.
PMID:
25241718
DOI:
10.1016/S0140-6736(14)61672-X
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center